Bibliographic Details
| Title: |
Anemia during treatment with peginterferon Alfa-2b/ribavirin and boceprevir: Analysis from the serine protease inhibitor therapy 2 (SPRINT-2) trial. |
| Authors: |
Sulkowski MS; Johns Hopkins University School of Medicine, Baltimore, MD 21287-0003, USA. msulkowski@jhmi.edu, Poordad F, Manns MP, Bronowicki JP, Rajender Reddy K, Harrison SA, Afdhal NH, Sings HL, Pedicone LD, Koury KJ, Sniukiene V, Burroughs MH, Albrecht JK, Brass CA, Jacobson IM |
| Corporate Authors: |
SPRINT-2 Trial Investigators |
| Source: |
Hepatology (Baltimore, Md.) [Hepatology] 2013 Mar; Vol. 57 (3), pp. 974-84. Date of Electronic Publication: 2013 Feb 11. |
| Publication Type: |
Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: |
Publisher: Wolters Kluwer Health, Inc Country of Publication: United States NLM ID: 8302946 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-3350 (Electronic) Linking ISSN: 02709139 NLM ISO Abbreviation: Hepatology Subsets: MEDLINE |
| Database: |
MEDLINE Ultimate |
